Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Association Between Multiple Sclerosis and Erectile Dysfunction: A Nationwide Case-Control Study.
[Cannabinoid drugs for neurological diseases: what is behind?].
Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis.
Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study.
Rectus abdominis muscle endometriotic mass in a woman affected by multiple sclerosis.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Naltrexone
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
Autoimmunity: Rubbing salt in the wound.
Glycerol rhizotomy and radiofrequency thermocoagulation for trigeminal neuralgia in multiple sclerosis.
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Immunology: A tolerant approach.
[Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a german high-volume clinic].

Pages